In December 2019 the International Equestrian Federation (FEI) has reported an anti-doping rule violation against the Finnish rider Jaana Kivimaki after her sample tested positive for the prohibited substance Furosemide. After notification the Athlete filed a statement in her defence.
The Athlete admitted the violation and denied the intentional use. With medical evidence she demonstrated that for her medical condition she used daily prescribed Furosemide since November 2018 while there is no alternative medication available as treatment.
The Athlete previously had not received anti-doping education and was unaware that she had to apply for a TUE. Not only did she mention her medication on the Doping Control Form she also told the Doping Control Officer that she had used prescribed Furosemide.
Hereafter the Athlete's application for a TUE for the use of Furosemide was granted by the ITA TUE Committee in February 2020. The approval of a retroactive TUE was rejected.
FEI accepted the Athlete's explanation, concluded that the violation was not intentional and that she bears No Significant Fault or Negligence. It considered that the Athlete had admitted the violation and that a TUE was approved. Further she had mentioned her medication on the Doping Control Form and had not received any anti-doping education.
The parties in this case reached an agreement and requested the FEI Tribunal to issue a Decision incorporating the terms of this agreement. The Athlete accepted the sanction and agreed to fulfil the Education Requirement within 1 year.
Therefore the FEI Tribunal decides on 7 February 2020 in accordance with the mutual consent of the Parties to impose a fine and a 2 month period of ineligibility on the Athlete.
